We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+7.65%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$939M
AUM Growth
+$86.2M
Cap. Flow
+$29.6M
Cap. Flow %
3.15%
Top 10 Hldgs %
46.18%
Holding
2,925
New
150
Increased
988
Reduced
857
Closed
215

Top Buys

Rank Stock Value
1
VXUS icon
Vanguard Total International Stock ETF
VXUS
+$5.37M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$3.7M
3
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$2.54M
4
QQQ icon
Invesco QQQ Trust
QQQ
+$2.12M
5
NVDA icon
NVIDIA
NVDA
+$1.88M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$6.88M
2
XLP icon
State Street Consumer Staples Select Sector SPDR ETF
XLP
+$4.62M
3
OCSL icon
Oaktree Specialty Lending
OCSL
+$825K
4
MGI
MoneyGram International, Inc. New
MGI
+$627K
5
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$562K

Sector Composition

Rank Sector Weight
1 Financials 16.18%
2 Technology 15.3%
3 Healthcare 6.27%
4 Consumer Discretionary 3.61%
5 Industrials 3.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MORF
2551
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$401 ﹤0.01%
+7
New +$366
IMVT icon
2552
Immunovant
IMVT
$8.25B
$398 ﹤0.01%
21
– –
AMPL icon
2553
Amplitude
AMPL
$1.41B
$396 ﹤0.01%
+36
New +$388
FAX
2554
abrdn Asia-Pacific Income Fund
FAX
$600M
$394 ﹤0.01%
24
– –
MYGN icon
2555
Myriad Genetics
MYGN
$312M
$394 ﹤0.01%
17
-57
-77% -$1.24K
DFH icon
2556
Dream Finders Homes
DFH
$1.36B
$393 ﹤0.01%
+16
New +$288
HRMY icon
2557
Harmony Biosciences
HRMY
$2.24B
$387 ﹤0.01%
+11
New +$380
ADEA icon
2558
Adeia
ADEA
$3.11B
$385 ﹤0.01%
35
– –
VITL icon
2559
Vital Farms
VITL
$525M
$384 ﹤0.01%
32
– –
NVEI
2560
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
$384 ﹤0.01%
13
-46
-78% -$1.62K
EFOR
2561
Everforth Inc
EFOR
$1.32B
$378 ﹤0.01%
+5
New +$359
EWBC icon
2562
East-West Bancorp
EWBC
$18B
$370 ﹤0.01%
7
– –
ABCL icon
2563
AbCellera Biologics
ABCL
$2.12B
$368 ﹤0.01%
57
+24
+73% +$164
LGTY
2564
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$368 ﹤0.01%
35
-111
-76% -$1.34K
AVNW icon
2565
Aviat Networks
AVNW
$273M
$367 ﹤0.01%
11
– –
SABR icon
2566
Sabre
SABR
$835M
$367 ﹤0.01%
+115
New +$416
GAIN icon
2567
Gladstone Investment Corp
GAIN
$661M
$365 ﹤0.01%
+28
New +$368
RXO icon
2568
RXO
RXO
$3.58B
$363 ﹤0.01%
16
– –
HAUZ icon
2569
Xtrackers International Real Estate ETF
HAUZ
$1.07B
$362 ﹤0.01%
18
– –
LZ icon
2570
LegalZoom.com
LZ
$988M
$362 ﹤0.01%
30
-332
-92% -$3.51K
MBC icon
2571
MasterBrand
MBC
$1.91B
$361 ﹤0.01%
31
-258
-89% -$2.47K
METCB icon
2572
Ramaco Resources Class B
METCB
$408M
$361 ﹤0.01%
+37
New +$357
CVI icon
2573
CVR Energy
CVI
$3.13B
$360 ﹤0.01%
12
– –
VECO icon
2574
Veeco
VECO
$3.23B
$360 ﹤0.01%
+14
New +$308
TBI
2575
Trueblue
TBI
$311M
$354 ﹤0.01%
+20
New +$339
101 102
103
104 105

Similar funds

SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
CHP
Cable Hill Partners Portland, Oregon $1.02B AUM 8.59% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
TAM
Taurus Asset Management New York $986M AUM 5.04% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.72% 1-Year Est. Return
CIG
CCM Investment Group Northfield, Minnesota $946M AUM
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
WCF
West Coast Financial Santa Barbara, California $876M AUM 5.74% 1-Year Est. Return

Lindbrook Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Lindbrook Capital held 2,925 positions worth $939M, up 10% from $853M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Lindbrook Capital deployed $29.6M of net new capital in Q2 2023, opening 150 new positions and adding to 988 existing holdings. Its largest new stake was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $6.88M trimmed.

  • Lindbrook Capital's largest Q2 2023 buy was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
  • Lindbrook Capital added most to Vanguard Total International Stock ETF in Q2 2023, an estimated $5.37M increase.
  • Lindbrook Capital's biggest Q2 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $6.88M.
  • Lindbrook Capital fully exited MoneyGram International, Inc. New in Q2 2023, selling an estimated $627K.
  • Lindbrook Capital's ten largest holdings make up 46% of its $939M portfolio in Q2 2023.
  • Lindbrook Capital opened 150 new positions and closed 215 in Q2 2023.
  • Lindbrook Capital's portfolio value rose 10% quarter-over-quarter to $939M.

Based on Lindbrook Capital's 13F filing for Q2 2023, filed 31 Jul 2023.